Alliance Pharma (LON:APH – Get Free Report) was downgraded by stock analysts at Berenberg Bank to a “hold” rating in a report issued on Wednesday, Marketbeat reports. They presently have a GBX 6,250 ($77.62) target price on the stock, down from their prior target price of GBX 7,000 ($86.93).
Alliance Pharma Stock Performance
Shares of APH stock opened at GBX 61.20 ($0.76) on Wednesday. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The firm has a 50-day moving average of GBX 50.26 and a 200-day moving average of GBX 44.25. Alliance Pharma has a one year low of GBX 24.55 ($0.30) and a one year high of GBX 61.60 ($0.77). The company has a market cap of £330.83 million, a P/E ratio of -1,020.00, a P/E/G ratio of 1.04 and a beta of 0.67.
Alliance Pharma Company Profile
Recommended Stories
- Five stocks we like better than Alliance Pharma
- Industrial Products Stocks Investing
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Market Cap Calculator: How to Calculate Market Cap
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- 3 Fintech Stocks With Good 2021 Prospects
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.